I mplant dentistry as a field has developed numerous advancements in materials and concepts that are designed to avoid alveolar ridge augmentation. However, there is still a pressing need for bone augmentation in situations where other techniques will not produce esthetic or functional results, such as cases of reduced horizontal or vertical bone volume. 1,2 Numerous alveolar ridge augmentation techniques have been developed, including autologous bone blocks from intra-and extraoral donor sites, ridge splitting and expansion, distraction osteogenesis, sandwich osteoplasty, and guided bone regeneration (GBR). 3 GBR is an extensively described alveolar ridge augmentation technique that has been shown to produce excellent, reproducible results and high long-term success rates based on high-evidence-level publications. [4] [5] [6] [7] [8] [9] GBR uses a resorbable or nonresorbable membrane to create and maintain a space over the bony defect and under the periosteum. Ideally, osteoprogenitor cells should colonize the space over the defect; however, these cells grow relatively slowly. The membranes used in GBR prevent the ingrowth of rapidly proliferating epithelial and connective tissue cells into the defect. GBR was first described by Nyman and Karring in 1979 as a means of guided tissue regeneration based on tissue engineering principles, and numerous studies on the technique were published thereafter. 4, [10] [11] [12] [13] [14] These early publications primarily used polytetrafluoroethylene (PTFE) membranes as a barrier. Several studies reported that this material had a high membrane exposure rate of 30% to 40%, [15] [16] [17] whereas other studies achieved very good results with no membrane exposure reported during the healing phase. [18] [19] [20] Due to its rigid mechanical properties, nonresorbable PTFE membranes can create and maintain the necessary space for GBR procedures, especially when the membrane is titanium reinforced. Using these membranes, the investigators achieved horizontal bone gain up to 9 mm and vertical bone gain up to 12 mm. 4, 5, 19, 20 In most studies reporting the use of these membranes, they were fixed to the underlying cortical bone with titanium pins or osteosynthesis screws to keep them in the desired position. 16, 21 Despite their effectiveness, nonresorbable membranes must be eventually removed, which requires surgically reopening the soft tissue. 18, 22 To avoid membrane removal surgeries, investigators developed resorbable materials, such as collagen membranes, in the early 1990s. Resorbable membranes have been studied extensively for guided tissue regeneration and GBR. [23] [24] [25] [26] [27] Nonchemically cross-linked bioresorbable membranes have good tissue and cell compatibility and lower dehiscence rates compared with PTFE membranes. To date, the biologic aspects of collagen membranes have been investigated thoroughly. [28] [29] [30] One challenging aspect of performing particulate grafts with resorbable membranes is identifying a method to fix the immobilized graft membrane at the desired position. This challenge is a key factor for successful GBR, because poor mechanical immobilization of the particulate graft under the fixed membrane results in increased dehiscence rates and reduced bone regeneration. 16 Several studies reported the use of resorbable or nonresorbable cortical bone pin systems or even sutures to fixate collagen membranes. [31] [32] [33] When nonresorbable pins are used, patients may need to undergo an additional surgery to remove the pins. Furthermore, the use of any pins, resorbable or nonresorbable, increases the risk of perforating important anatomical structures, such as the alveolar nerve, maxillary sinus, or roots of adjacent teeth.
To date, there are several systematic reviews or metaanalyses addressing GBR procedures using PTFE membranes. To the authors' knowledge, there is no such publication for resorbable collagen membranes, especially in combination with particulate graft materials, even though these materials are often used in daily practice. Additionally, there are no clear guidelines on the use of collagen membranes with respect to their indications and limitations. The aim of this meta-analysis was to identify relevant clinical studies on GBR using resorbable collagen membranes and particulate graft material for implant dentistry applications that have been reported within the last three decades. This analysis focuses on the quantity of regenerated bone, membrane exposure rate, and the implant survival rate in human studies. The secondary objective was to evaluate whether additional techniques, ie, membrane fixation and additional decortication, produce beneficial clinical outcomes.
MATERIALS AND METHODS

Literature Search
Two independent reviewers (B.W., W.Z.) performed an electronic literature search of the MEDLINE database for papers published between January 1980 and December 2014. The literature search was performed and reported according to the preferred reporting items for systematic reviews and meta-analysis (PRISMA) guidelines 34 ( Fig 1) . The last date that the literature was searched was December 20, 2014 Two independent reviewers assessed the abstracts of the selected publications to eliminate irrelevant publications. Publications were retained if they matched the inclusion criteria. If no abstract was available, the original article was used. Following abstract screening, the reviewers analyzed the full text to select the final articles. The reviewers also cross-checked the references of the selected articles to identify any undetected, relevant studies. Following their independent, full-text screenings, the reviewers compared their selections and discussed each publication individually prior to final article inclusion. Any discrepancies between the two reviewers regarding the inclusion of an article were resolved through a consensus discussion.
Study Selection
Publications were selected based on the Cochrane Collaboration's Patients, Intervention, Comparison, Outcomes (PICO) principle, described below.
Patients. The review included clinical studies of patients treated with dental implants that had simultaneous or previously performed GBR with collagen barrier membranes and particulate graft materials for horizontal and/or vertical bone augmentation. There were no restrictions concerning gender, age, diabetes, or smoking status. Patients with active periodontitis were excluded.
Intervention. The intervention was simultaneous or previously performed bone augmentation using GBR for dental implant therapy. GBR procedures needed to have been performed with particulate materials, such as autologous bone chips, and/or osteoconductive materials, such as allografts, xenografts, or alloplastic bone substitute materials. The GBR procedure needed to be part of a closed healing protocol. Studies had to use resorbable collagen membranes for inclusion.
Comparison. The following comparisons were made: (1) GBR procedures in which an immobilized collagen membrane was fixed to the underlying bone using a cortical pin system, sutures, or the cover screw of the implant were compared with GBR procedures in which the collagen membrane was applied to the grafted area, rehydrated with blood or sterile saline, and no further fixation methods were used; (2) GBR procedures with partial decortication in the augmented area were compared with GBR procedures without decortication.
Outcomes. The outcome measures included (1) implant survival rate, (2) membrane exposure rate, (3) bone gain with the quantity of regenerated bone measured as millimeters horizontal or vertical, and (4) bone loss observed during follow-up.
Study Design
Only randomized controlled trials (RCTs) with evidence level II-2 or higher (cohort or case-control analytic studies) based on the United States preventive services task force classification 35 were included.
Exclusion Criteria
Exclusion criteria were defined as follows: (1) animal or in vitro studies; (2) evidence level less than II-2; (3) studies in extraction sites or studies that used growth factors; (4) GBR to correct other indications, such as extraction sites, periodontal defects, or root resection defects; (5) studies with nonparticulate graft material morphology, such as bone blocks; (6) studies that used membranes other than resorbable collagen membranes; or (7) shorter follow-up publications of the same study (only one publication with the longest follow-up was used).
Data Extraction
The following information was extracted from selected publications: journal, name of author(s), publication year, study design, intervention type, membrane, graft material or membrane supporting material, time of implant placement (simultaneous or subsequent), membrane fixation method, decortication, mean healing time, membrane exposure rate, horizontal bone gain, vertical bone gain, bone loss, number of patients, number of implants, follow-up period, patients lost to follow-up, and implant survival rate.
If any relevant information was missing from the published results, corresponding authors were contacted via email. Data were entered into a piloted data extraction form (Microsoft Office Excel 2007) by one reviewer (first author) and proofread by a second reviewer (third author).
Quality Assessment and Risk of Bias
The possible risk of bias for the RCTs was determined using the Cochrane Collaboration's risk of bias (RoB) tool (Table 1) . 36 The risk of bias for the prospective studies was assessed using the Cochrane risk of bias tool for nonrandomized studies of interventions (ACROBAT-NRSI), 37 which is based on the RoB tool ( Table 2) .
Statistical Analysis
Following data extraction, study results were pooled for analysis by a statistician (second author). Several included studies reported a 100% implant survival rate based on the maximum likelihood estimator p = x/n. Because this estimate implies no variation, it is not useful for this purpose, especially in cases of a small n. Therefore, estimated survival rates were recalculated based on the midpoint estimate for the score interval p = (x + 1.96)/(n + 3.92). 38 To determine the effect on survival rates, generalized mixed-effect models were created using a binomial error estimate. The models included mean healing time, decortication, and fixation method as independent variables and accounted for random study effects. 39, 40 To determine effect on bone gain values, multilevel random effects models were created using the same fixed and random effects as those used for 
RESULTS
Study Identification and Selection
The electronic search produced 343 publications, and the hand search identified 5 additional publications. The identified publication abstracts were then screened to determine if they roughly met the inclusion criteria prior to a full-text review. In total, 81 publications met the criteria for full-text review. Of these 81 publications, 20 fulfilled all inclusion criteria for this systematic review. The PRISMA flowchart of the search strategy, identification, and selection process is shown in Fig 1 .
Risk of Bias
All included RCTs had a low risk of bias except the study by Carpio et al, 16 which had a moderate risk of bias. All three included prospective studies had a moderate risk of bias.
Descriptive Review of Study Characteristics
Of the 20 included publications, 17 reported on RCTs 6, 8, 9, 16, 19, [42] [43] [44] [45] 47, 49, 50, 51, [53] [54] [55] [56] and 3 reported on nonrandomized prospective studies. 46, 48, 52 Several studies reported on treatment arms that did not meet the inclusion criteria. For example, some studies had treatment arms that did not use membranes or used a non-collagen membrane. Additionally, some treatment arms had control groups that used bone blocks or the treatments were performed in extraction sites. These treatment arms were excluded from the review and meta-analysis. In total, 33 treatment or study arms were investigated. A summary of study characteristics for included treatment arms of the included publications is shown in Table   3 . 6, 8, 9, 16, 19, [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] Details of the GBR procedure for each treatment group and the outcomes evaluated in the included publications are shown in Table 4 . All of the included publications were well-designed clinical trials that largely provided the information needed for a systematic review, such as study design, study population, number of implants, number of implant sites undergoing GBR, follow-up period, and implant survival/failure rate. Unfortunately, some publications did not report critical data. In the two publications by Park et al, 53, 54 the overall population was reported, but it was unclear how many patients were in each study group. Altogether, 18 publications reported on 460 patients. 6, 8, 9, 16, 19, [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] 55, 56 In one publication by Friedmann et al, 8 the number of implants in each group was not provided. Publications by Carpio et al 16 and Meijndert et al 50 did not state how many implants were placed in each treatment arm. Overall, 17 publications reported on 733 implants. 6, 9, 19, [42] [43] [44] [45] [46] [47] [48] [49] [51] [52] [53] [54] [55] [56] The follow-up period of the studies was relatively short: 10 publications did not report beyond the second surgical procedure, 8, 16, 19, 43, 45, 46, 48, [51] [52] [53] 1 publication reported a 6-month follow-up, 47 4 publications reported a 12-month follow-up after surgical reentry, 42,44,49,50 2 publications reported a 24-month follow-up, 6,55 1 publication reported a 59-month followup, 56 and 1 publication reported a 72-month follow-up. 9 In one publication, the difference in follow-up between the two study groups could not be determined. 54 The overall mean follow-up time of the included publications was 8.77 months (range, 0-72 months). Only three publications did not report on patients lost to follow-up. 43, 53, 54 Fifteen publications reported on simultaneous GBR and implant placement, 6, 9, 16, 19, [42] [43] [44] [45] 47 ,48,52-56 4 publications reported GBR and subsequent implant placement following a healing period, 8,49-51 and 1 publication included both simultaneous and subsequent implant placement. 46 Implant survival or failure was reported in 15 publications (Table 3) . 6, 9, 16, 19, [42] [43] [44] 46, 47, [49] [50] [51] [52] [53] 56 The estimated implant survival rate calculated from those studies was 99.13% (95% CI, 97.23%-99.96%) (Fig 2) . The estimated survival rate for subsequent implant placement was 98.30% (95% CI, 92.49-99.97%), whereas the rate for simultaneous implant placement was 99.75% (95% CI, 99.75%-100%) (Fig 3) . There was no significant difference observed between simultaneous and subsequent implant placement with respect to implant survival rate.
Of the 33 included study arms, 21 reported on noncross-linked collagen membranes and 12 reported on cross-linked collagen membranes. Membrane exposure rate was reported in 25 study arms, and the overall estimated membrane exposure rate was 23.19% (95% CI, 12.70%-39.12%) (Fig 4) . The estimated exposure rate was 28.62% (95% CI, 14.14%-49.32%) for cross-linked membranes and 20.74% (95% CI, 11.16%-36.19%) for non-cross-linked membranes (Fig 5) .
Bone graft or membrane-supporting materials were well documented in all studies. Fourteen study arms used only anorganic bovine bone mineral (ABBM), 6 53 4 arms used ABBM and ABC with different concentrations, 16, 42, 51 3 arms used β-tricalcium phosphate/hydroxyapatite (β-TCP/HA), 44 ,47 2 arms used demineralized bone matrix (DBM), 48 1 arm used ABC and osteosynthesis material (OM), 9 and one arm used only HA. 55 The concentrations of the various supporting material in the composition grafts varied between different studies and between study arms in the same study.
The number of patients treated in the different grafting groups as well as the follow-up time differed widely between the studies and study arms, rendering a statistical evaluation of the different protocols unfeasible for most groups. The only group for which a further evaluation was possible was the one treated with pure ABBM. All of the sites in that group were augmented with the same product (Bio-Oss, Geistlich). With a mean follow-up time of 13 months (range 0-59.1 months), the mean implant survival rate in this group was 98.34 (95% CI, 96.06%-99.71%), independent of whether the GBR was simultaneous or prior to implant placement, and the estimated vertical bone gain with pure ABBM was 3.05 mm (95% CI, 2.33-3.77 mm). The healing time of the augmented bone was reported for all study arms except two. 53 Mean healing time including both simultaneous and subsequent implant placement was 5.88 months (95% CI, 3-8.1 months).
The indication for ridge augmentation was classified as horizontal for 27 study arms and vertical for 3 study arms. One study arm could not be classified. Six publications (9 study arms) did not report vertical or horizontal bone gain or loss. 6, 8, 48, 50, 54, 55 The results in the remaining publications varied widely in presentation (eg, gain/loss, horizontal/vertical, depth/width, mesial/distal, coronal/apical, and volume/length/percentage) and rarely presented dispersion parameters. This variation made it difficult, and in some cases unfeasible, to compare studies with respect to bone gain or loss parameters.
Among those studies reporting bone gain, the overall mean horizontal bone gain (depth perpendicular to the implant axis) was 2.27 ± 1.68 mm and the mean vertical bone gain was 3.05 ± 1.02 mm (Tables 5 and 6 ). Only 1 publication (2 study arms) reported horizontal bone gain (width) in the mesiodistal direction on the implant surface. 45 In that study, the horizontal bone gain width was 2.65 ± 2.27 mm for the tested crosslinked membrane and 2.65 ± 2.36 mm for the tested non-cross-linked membrane. Bone loss results were only reported in 5 publications (6 study arms). 9, 42, 44, 49, 56 The overall mean vertical bone loss was 0.68 mm (range, 0.11-1.34 mm), with a mean observation period of 33.42 months (range, 12-72 months).
With regard to membrane fixation, 6 arms did not report whether membranes were fixed and 1 was too ambiguous to assign with certainty. 16, 42, 47, 54, 55 Twenty arms reported that membranes were not fixed, 8, 9, [43] [44] [45] [46] [51] [52] [53] and 6 reported fixation with either cortical pins 6, 16, 19, 56 or sutures. 49, 50 Because none of the study arms reported on both horizontal bone gain and membrane fixation, two comparable groups could not be created. Therefore, the meta-analysis was performed only on collagen membrane fixation and vertical bone gain, which included 7 study arms without and 1 study arm with fixation. Mean vertical bone gain without membrane fixation was 2.94 ± 1.05 mm and 4.25 mm with fixation (Table 5 ).
In 11 study arms, no statements were made regarding decortication. 16, 42, 47, 48, 52, 54, 55 Among the remaining study arms, 20 reported that decortication was performed 6, 8, 9, [44] [45] [46] [49] [50] [51] 53, 56 and 2 specifically stated that decortication was not performed. 43 Mean vertical bone gain was 3.25 ± 2.05 mm without decortication and 3.05 ± 0.88 mm with decortication (Table 5 ). Mean horizontal bone gain was 0.85 ± 0.35 mm without decortication and 2.98 ± 1.63 mm with decortication (Table 6) .
DISCUSSION Main Findings
The number of publications addressing GBR for ridge augmentation using resorbable collagen membranes has increased substantially over the last two decades. The aim of this systematic review was to summarize the available literature regarding GBR for ridge augmentation using particulate graft material and resorbable collagen membranes to devise evidence-based recommendations and answer the following question: Does collagen membrane fixation or decortication affect the amount of newly regenerated bone when performing GBR?
The systematic literature search yielded numerous publications reporting on clinical studies with widely varying study designs, outcome documentation, and publication methods. The identified publications included a large number of case reports, case series, and retrospective analyses. Due to the risk of uncontrolled bias, only RCTs or prospective controlled studies were included in the review. Immediate implant placement and the use of growth factors were also excluded because they introduced additional biologic factors into the analysis. These exclusion criteria eliminated all but 17 RCTs and 3 prospective controlled studies, which were then screened for quality assessment and data extraction. Among those studies, 16 RCTs had a low risk of bias, and 1 RCT and 3 prospective controlled studies had a moderate risk. Thus, all the identified studies were included in data extraction. Because only RCTs and prospective controlled trials were included, there were one or more study arms in each publication that could be designated as a control group. For data extraction, only study arms that used resorbable collagen membranes and particulate graft materials were included.
Overall, 460 patients receiving 733 implants were included in this review and analysis. The overall mean healing time was 5.88 months. This time is consistent with the 3-to 6-month healing time associated with bone augmentation of alveolar ridges. 57, 58 The overall mean follow-up time was 9.72 months (range, 0-72 months) after surgical reentry. Only two studies reported follow-up periods of at least 5 years. 9, 56 All but three publications reported on patient loss to followup. The overall estimated implant survival rate in this analysis was 99.13% (95% CI, 97.23%-99.96%), which was much higher than that reported in another systematic review by Aghaloo and Moy evaluating GBR with any membrane type. 3 However, Aghaloo and Moy excluded studies with a follow-up period shorter than 12 months, which could substantially influence the overall survival rate. When looking at the distribution of implant failures, 20 study arms reported no implant loss, 5 arms reported 1 lost implant, 3 arms reported 2 lost implants, and 1 study reported 5 lost implants. All study arms reporting at least one loss were part of larger studies with more patients. This could indicate potential publication bias produced by smaller studies with respect to implant loss. The high number of publications with short follow-up periods can be explained by the primary outcome of these investigations, which was the amount of bone gain at surgical reentry. In the current review, the implant survival rates for simultaneous and subsequently placed implants were 99.75% and 98.3%, respectively. While there was a 1.45% difference in implant survival depending on implant placement timing, it was not statistically significant. Furthermore, it seems unlikely that the difference would be clinically relevant. With this equivalence in mind, simultaneous GBR and implant placement has several advantages, such as reduced numbers of surgeries, which lowers the risk of morbidity, reduces healing time, and increases patient comfort. The simultaneous approach is often the preferred method for correcting alveolar ridge defects during implant placement.
Analysis of studies that had used particulate ABBM for GBR with collagen membranes showed high implant survival rates of 98.34% and an estimated vertical defect reduction of 3.05 mm with a mean follow-up time of 13 months. Unfortunately, due to the limited number of study arms and variability of study arms, no other comparisons were statistically feasible.
Numerous studies have noted a difference in membrane exposure rates between non-cross-linked and cross-linked collagen membranes, although reports differ widely for both groups. 22, 43, 45 In this review, the membrane exposure rate was 28.62% for crosslinked membranes and 20.74% for non-cross-linked membranes. Again, this difference is not statistically significant. The current evidence slightly favors the use of non-cross-linked membranes due to the lower exposure rates. Because there were no publications reporting the difference in bone gain in patients with and without membrane exposure, the direct outcome of membrane exposure could not be determined in this review. Another systematic review by Sanz-Sán-chez et al 59 comparing several techniques and materials for lateral ridge augmentation showed that bone gain with respect to defect reduction was significantly higher in nonexposed sites. This observation also agrees with a meta-analysis by Machtei evaluating the effect of membrane exposure on the amount of newly regenerated bone. 60 The overall mean horizontal bone gain (ie, the depth perpendicular to the implant axis) was 2.27 ± 1.68 mm. The mean vertical bone gain was 3.05 ± 1.02 mm. The one study reporting the horizontal bone gain (width) in the mesiodistal direction had a mean value of 2.64 mm. 45 In a systematic review evaluating the effectiveness of lateral bone augmentation on alveolar crest dimensions, the mean bone gain for all studies was 3.90 mm (95% CI, 3.52-4.28 mm) 59 ; the authors of that review included a broader range of experimental methods including the use of bone blocks and growth factors. When looking at the values for equivalent methods, the results of the present study are similar to those reported in their analysis.
Only four studies reported on radiographically confirmed vertical bone loss during follow-up. In these studies the overall mean vertical bone loss was 0.968 ± 0.258 mm with a mean observation period of 33.42 months (range, 12-72 months). The different treatment modalities could not be compared due to differences in reporting and study design. The highest vertical bone loss value, 1.34 mm, was measured at the 5-year follow-up of a long-term study. 56 According to the success criteria devised by Albrektsson et al, 61 all of the implants included in this analysis were successful based on their bone resorption values.
Role of Membrane Fixation and Decortication
The results of this meta-analysis indicate that the amount of newly regenerated vertical bone is much higher when the collagen membrane is fixed (mean 4.25 mm) than when it is not (mean 2.94 mm), even though this difference did not reach statistical significance. Because the amount of evidence for the compared groups differed substantially, it is difficult to draw conclusions from this result. Of the 6 study arms reporting on fixed membranes, only 1 reported bone gain, whereas 7 of the 21 arms reporting on membranes without fixation reported bone gain. The increased bone gain seen with fixed membranes can be explained by one of the basic principles of GBR, ie, that a space should be maintained under the membrane to prevent its collapse. Fixing the membrane immobilizes the particulate bone graft at the desired position. It also prevents migration of the graft into surrounding tissues during suturing and volume loss. 31 Decortication may affect the amount of horizontal bone gain. In this review, the mean horizontal bone gain (depth, perpendicular to the alveolar ridge) was 2.98 mm with decortication and 0.85 mm without decortication. Numerous publications have reported that perforation of the alveolar corticalis gives progenitor cells more access to the grafted site and ensures better nutrition and revascularization, especially in cases of dense bone. 6, 31, 45 A review of animal studies investigating bone decortication for GBR could not determine the impact of this technique because of the small number of trials included and heterogeneous study protocols. 62 In that review, there were only 2 study arms reporting on GBR without decortication compared with 20 arms with decortication. Additionally, one of the GBR without decortication study arms used a cross-linked membrane that has had a high membrane exposure rate (56%). 43 However, cortical perforation seemed to have no effect on vertical bone gain when considering arms within the same study, indicating that perforation of the alveolar corticalis may have a positive effect on more distant areas of the graft, such as perpendicular to the implant axis or the alveolar ridge.
CONCLUSIONS
The literature search identified enough evidence-based data from relevant clinical studies to perform a systematic review and meta-analysis on GBR with particulate graft material and resorbable collagen membranes.
Based on the findings of this systematic review and meta-analysis, GBR with particulate graft material and resorbable collagen membranes is an effective technique for lateral alveolar ridge augmentation prior to or simultaneously with dental implant placement, having similar implant survival rates compared to pristine bone. Therefore, it can be concluded that a simultaneous approach is indicated whenever possible, as it reduces the number of surgeries, which lowers morbidity, reduces treatment time, and increases patient comfort. Statements for vertical ridge augmentation with the mentioned materials cannot be given to date based on the available data.
Anorganic bovine bone mineral is an effective grafting material for GBR that provides sufficient newly regenerated bone as well as high implant survival rates.
Early exposure of collagen membranes during GBR is a relatively common complication and has to be expected in approximately one-fifth of the cases. Although the membrane exposure rates for cross-linked membranes were 30% higher than for non-cross-linked membranes, a direct effect on the quantity of bone gain as well as implant outcomes could not be identified in this meta-analysis.
The results of the meta-analysis showed weak evidence that the fixation of collagen membranes with pins or sutures increased the amount of newly regenerated bone. Decortication of the alveolar cortical bone also led to an increased alveolar ridge width, even though these values did not reach statistical significance. These findings may represent beneficial additional techniques for the practice when performing GBR.
